Comparación del efecto curativo entre la cirugía artroscópica y la onda de choque extracorpórea en el tratamiento de la artrosis de rodilla
A total of 90 patients with knee osteoarthritis who met the inclusion criteria were selected as the research subjects. According to the different treatment methods selected by the patients, the 90 patients were divided into a shock wave group (using extracorporeal shock wave therapy) and an arthroscopy group (using arthroscopic surgery). ), 45 cases in each group, and 15 cases in each group were divided into Ⅰ, Ⅱ and Ⅲ grades according to Kellgren-Lawrecne classification (K-L classification). The shock wave group received shock wave therapy on the pain points of the affected knee, the shock wave frequency was 10 Hz, the treatment pressure was 3 bar (1 bar=100 kPa), and each pain point was impacted 2000 times, once a week, for a total of 5 times; the arthroscopy group received arthroscopy Surgical treatment. Before treatment and at 1, 3, and 6 months after treatment, the K-L grading of the two groups was assessed using Lysholm functional score, Western Ontario and McMaster University Osteoarthritis Index (WOMAC) score and visual analogy (VAS) pain score. The knee joint functional activities and pain conditions of patients with grades Ⅰ-Ⅲ were evaluated and statistically analyzed and compared. Results After treatment, the Lysholm score, WOMAC score and VAS score of shock wave group and arthroscopy group were significantly different from those before treatment (P<0.05). Compared with the arthroscopy group at the same time point, there was no significant difference (P>0,05); los pacientes del grupo de ondas de choque KL grado II y III tuvieron mejores puntuaciones en cada punto de tiempo después del tratamiento que el grupo de artroscopia (P<0,05). Conclusión La intervención temprana para la artrosis de rodilla es necesaria; La terapia de ondas de choque extracorpóreas parece ser superior a la cirugía artroscópica para aliviar el dolor articular y mejorar la función de la rodilla en pacientes con osteoartritis de rodilla de grado II y III.
